1 completed, 1 withdrawn. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Gly-low: new trials by email Literature Review of Gly-low trials Research Report on Gly-low
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methylglyoxal (MGO) Lowering Cocktail to Reduce Appetite in Obese Individuals Gly-low, Placebo - Obesity, Aging | Phase 1 / Phase 2 | Withdrawn | University of California, San Francisco | 2024-12-01 | 2025-08-29 | |
| Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity GLY-LOW - Insulin Resistance, Obesity | Early Phase 1 | Completed | Hoskinson Health and Wellness Clinic | 13 | 2023-07-27 | 2025-06-10 |
Obesity (2) · Cardiovascular Diseases (1) · Cognitive Dysfunction (1) · Depression (1) · Hyperlipidemias (1) · Hyperphagia (1) · Hypertension (1) · Inflammation (1) · Insulin Resistance (1) · Sedentary Behavior (1)
Hoskinson Health and Wellness Clinic (1) · University of California, San Francisco (1)
United States (2)
Marshall Stoller, MD (1) · Sanjay Dhar, PhD (1)